Clinical Trial Update: Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pregnenolone for depression in individuals with bipolar disorder or recurrent major depressive disorder with substance use has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Substance Use Disorder

Drugs mentioned

• Pregnenolone (pregnenolone)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Bipolar Disorder, Major Depressive Disorder | Phase 4 | Status: COMPLETED